GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Icecure Medical Ltd (XTAE:ICCM) » Definitions » Deferred Policy Acquisition Costs

Icecure Medical (XTAE:ICCM) Deferred Policy Acquisition Costs


View and export this data going back to 2011. Start your Free Trial

What is Icecure Medical Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Icecure Medical (XTAE:ICCM) Business Description

Traded in Other Exchanges
Address
7 Haeshel Street, Southern Industrial Park, PO Box 3163, Caesarea, ISR, 3079504
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.